Selected recent publications:

• Kato M, Nakamura Y, Suda T, Ozawa Y, Inui N, Seo N, Nagata T, Koide Y, Kalinski P, Nakamura H, Chida K. Enhanced anti-tumor immunity by superantigen-pulsed dendritic cells. Cancer Immunology, Immunotherapy [Internet]. 2011:1-10.
• Yang D-, Kim M-, Lee Y-, Hong CY, Lee HJ, Nguyen-Pham T-, Bae SY, Ahn J-, Kim Y-, Chung I-, Kim H-, Kalinski P, Lee J-. Successful cross-presentation of allogeneic myeloma cells by autologous alpha-type 1-polarized dendritic cells as an effective tumor antigen in myeloma patients with matched monoclonal immunoglobulins. Ann Hematol [Internet]. 2011:1-8.
• Wong JL, Mailliard RB, Moschos SJ, Edington H, Lotze MT, Kirkwood JM, Kalinski P. Helper activity of natural killer cells during the dendritic cell-mediated induction of melanoma-specific cytotoxic T cells. Journal of Immunotherapy [Internet]. 2011;34(3):270-8.
• Li J, O'Malley M, Urban J, Sampath P, Guo ZS, Kalinski P, Thorne SH, Bartlett DL. Chemokine expression from oncolytic vaccinia virus enhances vaccine therapies of cancer. Molecular Therapy [Internet]. 2011;19(4):650-7. 
• Zhao X, Bose A, Komita H, Taylor JL, Kawabe M, Chi N, Spokas L, Lowe DB, Goldbach C, Alber S, Watkins SC, Butterfield LH, Kalinski P, Kirkwood JM, Storkus WJ. Intratumoral IL-12 gene therapy results in the crosspriming of tc1 cells reactive against tumor-associated stromal antigens. Molecular Therapy [Internet]. 2011;19(4):805-14.
• Wieckowski E, Chatta GS, Mailliard RM, Gooding W, Palucka K, Banchereau J, Kalinski P. Type-1 polarized dendritic cells loaded with apoptotic prostate cancer cells are potent inducers of CD8+ T cells against prostate cancer cells and defined prostate cancer-specific epitopes. Prostate [Internet]. 2011;71(2):125-33.
• Okada H, Kalinski P, Ueda R, Hoji A, Kohanbash G, Donegan TE, Mintz AH, Engh JA, Bartlett DL, Brown CK, Zeh H, Holtzman MP, Reinhart TA, Whiteside TL, Butterfield LH, Hamilton RL, Potter DM, Pollack IF, Salazar AM, Lieberman FS. Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with α-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma. Journal of Clinical Oncology [Internet]. 2011;29(3):330-6.
• John E, Laskow TC, Buchser WJ, Pitt BR, Basse PH, Butterfield LH, Kalinski P, Lotze MT. Zinc in innate and adaptive tumor immunity. Journal of Translational Medicine [Internet]. 2010;8
• Muthuswamy R, Mueller-Berghaus J, Haberkorn U, Reinhart TA, Schadendorf D, Kalinski P. PGE2 transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells. Blood [Internet]. 2010;116(9):1454-9.
• Lesinski GB, Carson WE, Repasky EA, Wei W-, Kalinski P, Lotze MT, June CH, Petros W, Muthusamy N, Olencki T. Meeting report: The 13th annual meeting of the translational research cancer centers consortium (trc3); immune suppression and the tumor microenvironment, columbus, ohio; march 1-2, 2010. Journal of Immunotherapy [Internet]. 2010;33(7):659-62.
• Zhu X, Fallert-Junecko BA, Fujita M, Ueda R, Kohanbash G, Kastenhuber ER, McDonald HA, Liu Y, Kalinski P, Reinhart TA, Salazar AM, Okada H. Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-α and IFN-γ dependent manners. Cancer Immunology, Immunotherapy [Internet]. 2010;59(9):1401-9.
• Kalinski P, Okada H. Polarized dendritic cells as cancer vaccines: Directing effector-type T cells to tumors. Semin Immunol [Internet]. 2010;22(3):173-82.
• Yang D-, Kim M-, Hong CY, Lee Y-, Jin C-, Pham T-N, Ahn J-, Bae W-, Kim Y-, Chung I-, Kim H-, Kalinski P, Lee J-. Alpha-type 1-polarized dendritic cells loaded with apoptotic allogeneic myeloma cell line induce strong CTL responses against autologous myeloma cells. Ann Hematol [Internet]. 2010:1-7.
• Helfer BM, Balducci A, Nelson AD, Janjic JM, Gil RR, Kalinski P, De Vries IJM, Ahrens ET, Mailliard RB. Functional assessment of human dendritic cells labeled for in vivo 19F magnetic resonance imaging cell tracking. Cytotherapy [Internet]. 2010;12(2):238-50.
• Kalinski P, Wieckowski E, Muthuswamy R, de Jong E. Generation of stable Th1/CTL-, Th2-, and Th17-inducing human dendritic cells. Methods Mol Biol [Internet]. 2010;595:117-33.

CONTACT INFORMATION

Dr. Pawel Kalinski
Phone: (412) 623-7712
Email: kalinskip@upmc.edu